• Corpus ID: 37354889

Scientific opinion on the regulatory status of 1,3-dimethylamylamine (DMAA).

  title={Scientific opinion on the regulatory status of 1,3-dimethylamylamine (DMAA).},
  author={Bastiaan J. Venhuis and D. de Kaste},
1,3-Dimethylamylamine (DMAA) is a pressor amine often found in food supplements for athletes at dosages of 25-65 mg. Historically, the compound has been used as a nasal decongestant but its oral application is largely unstudied leaving the regulatory status of such food supplements as unlicensed medicines undetermined. We therefore reviewed the literature on DMAA and similar amines in order to deduce an effective oral dosage. Based on our findings we conclude that oral preparations with >4 mg… 

Tables from this paper

Physiological and pharmacokinetic effects of oral 1,3-dimethylamylamine administration in men
Findings indicate a consistent pattern of increase across subjects with regards to peak DMAA concentration, with peak values approximately 15–30 times lower than those reported in case studies linking DMAA intake with adverse events.
A synthetic stimulant never tested in humans, 1,3-dimethylbutylamine (DMBA), is identified in multiple dietary supplements.
Supplements containing DMBA were marketed to improve athletic performance, increase weight loss and enhance brain function and Regulatory agencies should act expeditiously to warn consumers and remove DMBA from all dietary supplements.
Examination of some toxicological parameters of dimethylamylamine when consumed alone or with caffeine
DMAA exhibits cytotoxic effects via membrane dysfunction and mitotic disturbance following increased oxidative stress in a dose- and caffeine-dependent manner, and this can have serious adverse effects on health.
When contaminated dietary supplements cause positive drug tests: methylhexaneamine as a doping agent in sport
Methylhexaneamine (DMAA), an amphetamine derivative banned by the World Anti-Doping Agency (WADA) in 2009, has caused more positive tests than any other stimulant.
"Plant or poison": A netnographic study of recreational use of 1,3-dimethylamylamine (DMAA).
Pharmacologically effective red yeast rice preparations marketed as dietary supplements illustrated by a case report.
A typical statin-related adverse reaction from a red yeast rice (RYR) supplement and the analytical findings from the supplement are reported and the regulatory framework governing botanical supplements in Europe is examined.
A health risk for consumers: the presence of adulterated food supplements in the Netherlands
The aim of this paper is to report the results of analyses of (adulterated) food supplements conducted by the Netherlands Food and Consumer Product Safety Authority between October 2013 and October 2018, finding that daily doses of the substances in the food supplements were sometimes much higher, causing a risk for consumers who are unaware of the presence of these pharmacologically active substances.
Anabolic steroids detected in bodybuilding dietary supplements - a significant risk to public health.
Several of the products tested contained steroids that may be considered to have considerable pharmacological activity, based on their chemical structures and the amounts present, which could unwittingly expose users to a significant risk to their health, which is of particular concern for naïve users.
Getting up to speed with the public health and regulatory challenges posed by new psychoactive substances in the information age.
Addiction has drawn together a collection of papers that have been published over the last few years, as a virtual issue which considers the challenges presented by these new psychoactive substances, and elaborating the policy challenges the authors now face, particularly in relation to public health and regulatory responses.


1,3-Dimethylamylamine (DMAA) in supplements and geranium products: natural or synthetic?
The enantiomeric and diastereomersic ratios of two different known synthetic DMAA compounds, as well as the total concentrations of DMAA and its stereoisomeric ratios in 13 different supplements, were determined by gas chromatography.
The effect of volatile 1-cyclohexyl-2-methylaminopropane ("Benzedrex" inhaler) on patients with coronary arteriosclerosis.
By using excessive inhalation doses, this paper has tried to bring out any of its deleterious side-effects on the cardiovascular system of patients with arteriosclerotic heart disease in order to determine whether or not they could safely use the inhaler in the treatment of upper-respiratory infections.
Comparison of pressor action of alicyclic derivatives of aliphatic amines.
2-Methylamino-1-cyclopentyl-propane has the usual effects of sympathomimetic amines on smooth muscle organs and continuous administration of this compound in food to rats in concentrations varying from 0.01 to 0.1 per cent for a period of 27 days does not result in pathological changes of visceral organs.
Determination of Tuaminoheptane in Doping Control Urine Samples
A confirmatory gas chromatographic-mass spectrometric procedure was developed including liquid–liquid extraction and imine formation of tuaminoheptane employing various aldehydes and ketones such as formaldehyde, acetaldehyde, benzaldehyde and acetone, which validated with regard to recovery, lower limit of detection and interday- and intraday precision.
Studies of methylhexaneamine in supplements and geranium oil.
This communication shows that geranium oils do not contain methyl hexaneamine and that products labelled as containing geranium oil but which contain methylhexaneamine can only arise from the addition of synthetic material.
Detection in urine of 4-methyl-2-hexaneamine, a doping agent.
The pharmacology of 2-amino-6-methylheptane.
  • E. J. Fellows
  • Chemistry, Biology
    The Journal of pharmacology and experimental therapeutics
  • 1947
Examination of the tissues removed from animals disclosed that this compound did not induce histropathologically demonstrable damage and acute toxicity data were obtained on 2-amino-6-methylheptane hydrochloride in mice, rats, rabbits and guinea-pigs.
Comparison of the effects of D-(-)-ephedrine and L-(+)-pseudoephedrine on the cardiovascular and respiratory systems in man.
The efficacy of pseudoephedrine as a nasal decongestant pointed out and explained in relation to its effect on alpha-adrenoceptors in the nasal blood vessels and the reasons for differences between the isomers are discussed.
A pharmacological study of certain alkoxyalkylamines.
  • T. Miya, L. D. Edwards
  • Chemistry
    Journal of the American Pharmaceutical Association. American Pharmaceutical Association
  • 1953
A series of alkoxyalkylamines has been tested for vasoconstrictor activity. The most active of the series, Compound D-9 [2-amino-3-(2-methylpropoxy)propane], is cornared pharmacologically with
The comparative pharmacology of the isomeric nitrogen methyl substituted heptylamines.
Nitrogen methylation did not uniformly increase or decrease the toxicity of any given agent and the 4-methyl-2-hexyl compounds were more active than the 2-heptyl derivatives.